Biosimilars: informing patients and physicians
What does the future treatment landscape of myeloma look like?
Can maintenance therapy improve patient outcome?
Mathias J Rummel
The history of collaboration in acute promyelocytic leukemia (APL) research
Francesco Lo Coco
The importance of collaboration across fields and institutions